ir.apolloreit.com
Apollo REIT - Investor Relations Home
DRIP and Stock Purchase Plan. Apollo Commercial Real Estate Finance, Inc. Reports Second Quarter 2015 Financial Results and Declares a Common Stock Quarterly Dividend of $0.44 Per Share. Mergers and Acquisition Announcement. There are currently no events scheduled. 160; 0.01. Data Provided by Thomson Reuters. You are now leaving our website. Apollo Commercial Real Estate Finance assume no responsibility for information or statements you may encounter on the Internet outside our website.
ir.apolloresidentialmortgage.com
APOLLORESIDENTIALMORTGAGE.COM
Drip and Direct Stock Purchase Plan. Q2 2015 Apollo Residential Mortgage Earnings Conference Call. 160;at 11:00 am ET. Q2 2015 Apollo Residential Mortgage Earnings Conference Call. Thursday, August 6, 2015 . 11:00 am ET . Click here for webcast. Click here to add this event to your calendar. 160; 0.1. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Mergers and Acquisition Announcement. Apollo Residential Mortgage, Inc. Reports Second Quarter 2015 Financial Results. NEW YORK- (BUSINESS WIRE)- Au...
ir.appfolioinc.com
Investor Overview | AppFolio, Inc.
We create easy-to-use, cloud-based software that helps small and mid-sized businesses more effectively market, manage and grow their business. Today, our products serve the legal and property management industries. 160; 0.35. AppFolio, Inc. Announces Second Quarter 2015 Financial Results. AppFolio, Inc. Announces Date of Second Quarter 2015 Financial Results Release. AppFolio, Inc. Announces Exercise and Closing of Over-Allotment Option for Initial Public Offering. There are currently no events scheduled.
ir.applehospitalityreit.com
Corporate Overview - Apple Hospitality Reit
RESIDENCE INN, BURBANK, CALIFORNIA. Apple Hospitality REIT, Inc. (NYSE: APLE) owns one of the largest portfolios of upscale, select service hotels in the United States. Our national, geographically diverse portfolio consists of 235 Hilton. Branded hotels located across 33 states, serving some of the country’s top markets for business and leisure travelers. And our hotels operate exclusively under some of the nation’s leading brands: Courtyard by Marriott. Fairfield Inn by Marriott. Hampton Inn by Hilton.
ir.applied.com
Investor Relations Home | Applied Industrial Technologies | Applied.com
Applied Industrial Technologies is a leading North American distributor of industrial products and services. Why Invest in Applied? E-mail the Board of Directors. Q4 2015 Applied Industrial Technologies Earnings Conference Call. 160;at 10:00 am ET. Q4 2015 Applied Industrial Technologies Earnings Conference Call. Wednesday, August 12, 2015 . 10:00 am ET . Click here for webcast. Click here to add this event to your calendar. 160; 0.23. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. CLEVELAND, ...
ir.approachresources.com
Approach Resources - Investors
Approach Resources Inc. (NASDAQ: AREX) is an independent oil and gas company headquartered in Fort Worth, Texas. Our operations are focused on exploration, development, production and acquisition of oil and gas properties. We own a leading position in the southern Midland Basin of the greater Permian Basin in West Texas, where we are developing the horizontal Wolfcamp shale oil play. Approach Resources Inc. Reports Second Quarter 2015 Results. View All News Releases. Abundant, Low-cost drilling targets.
ir.apricusbio.com
Investor Home | Investors | Apricus Biosciences
Mission / Vision / Values. Annual Meeting of Stockholders. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. 160;at 10:00 am ET. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. Wednesday, August 12, 2015 . 10:00 am ET . Click here for webcast. Click here to add this event to your calendar. Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Twelve Additional Countries. RayVa Phase 2a Trial Top...
ir.aptevotherapeutics.com
Investor Home : Investors : Aptevo
Aptevo Therapeutics and the ADAPTIR (Modular Protein Technology) Platform: The Future of Immuno-oncology. 160; 0.08 (3.21%). Updated January 13, 2017 4:00 pm ET. Stacey L. Jurchison. Senior Director, Investor Relations and Corporate Communications. Aptevo Therapeutics Inc at 29th Annual ROTH Conference. Aptevo Therapeutics Inc at the 16th Annual PEPTALK Conference. Aptevo Therapeutics Inc at Piper Jaffray 28th Annual Healthcare Conference.
ir.aptg.com.tw
A+ Asia Pacific Telecom Website
ir.aptose.com
Aptose Biosciences - Investors - Overview
SELECT SOLID TUMOR INDICATIONS. CDX2 AND KRUPPEL-LIKE FACTOR BIOLOGY. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. January 10, 2017. 160;at 9:00 am PT. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. Tuesday, January 10, 2017 . 9:00 am PT . Click here for webcast. Click here to add this event to your calendar. January 5, 2017. Aptose Biosciences to Present at Biotech Showcase 2017 Conference. December 29, 2016. Aptose Biosciences Provides Update on APTO-253 Development.
ir.aqr.com
AQR Capital - Investor Relations - Overview
Investor and Media Contact. There are currently no news releases. Primary IR and Media Contact. Quotes delayed at least 15 minutes. Market data provided by Interactive Data. Powered and implemented by Interactive Data Managed Solutions.